News

As Agentic AI transforms enterprise operations, Cisco’s Chuck Robbins sees opportunity in private cloud infrastructure amid ...
Live Updates Live Coverage Updates appear automatically as they are published. Still no earnings at 7:05 a.m. ET 7:04 am by ...
At the Global First Partners Academy, the wives of world leaders get a rare chance to connect and compare notes.
It finally happened! I took my Ford Bronco off-road for the very first time—and it did not disappoint. From deep ruts to ...
Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.
Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.